Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06284473 · ClinicalTrials.gov registry record · Phase 4

Ketamine as a Supplement to Local Anesthesia for Minor Procedures

A Phase 4 study of Abscess and Pain, Procedural, sponsored by Loyola University.

Recruiting
Registry status
Phase 4
Development phase
108
Enrollment target
1
Study location

NCT06284473: Recruiting Phase 4 study of Abscess and Pain, Procedural, sponsored by Loyola University.

NCT06284473 is a Phase 4 study of Abscess and Pain, Procedural that is actively recruiting participants, run by Loyola University. The registered enrollment target is 108 participants, below the 382-participant average among 13 other Abscess trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06284473, a Phase 4 study of Abscess and Pain, Procedural, is actively recruiting participants, sponsored by Loyola University.

RECRUITING
Registry status
Phase 4
Development phase
108 participants
Enrollment target
1
Study location

Study Summary

This trial is a double-blind randomized controlled clinical trial of adults and children (ages 7 to less than 70 years). Patients who present to the ED and who undergo minor bedside procedures that require local anesthesia will be divided into two groups: The first group will be treated with 0.7 mg/kg intranasal ketamine as well as standard local anesthesia for the procedure (treatment cohort). The second group will be treated with a volume-based dose of intranasal saline solution as well as standard local anesthesia for the procedure (control cohort). The primary aim is to assess whether patients in the treatment cohort report lower pain scores on the Numerical Rating Scale (NRS-100) when compared to patients in the control cohort. For adult patients, a secondary aim is to compare agitation between the two cohorts using the Richmond Agitation Sedation Scale (RASS) and, for pediatric patients, a secondary aim is to compare alertness between the two cohorts using the University of Michigan Sedation Scale (UMSS). Results obtained from specific procedures will be analyzed on a spectrum of complexity and general length of recovery time. Scientific achievements may include finding a safe and effective way to reduce pain and discomfort during minor procedures in the Emergency Department. Additionally, it would provide opportunities for more research on sub-dissociative doses of ketamine during minor procedures: a topic in which there is still a gap in the published research

Primary Outcome

Pain will be measured using the numeric rating scale which is a scale ranging from 0 to 100, where higher values report greater pain

Interventions

  • DRUG Ketamine
  • OTHER Saline

Study Locations (1)

Illinois

  • Loyola University Medical Center - Maywood

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2022-05-25
Est. Completion 2028-05-31
Phase Phase 4
Loyola University

92 total trials

What NCT06284473 shows while recruiting

NCT06284473 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 382-participant average among 13 other Abscess trials with a reported enrollment target (72% lower).

The record links to 3 conditions, with Abscess appearing as the primary indexed condition, and to 2 interventions - of which Ketamine is the first listed.

NCT06284473 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT06284473 about?

NCT06284473 is a clinical study titled "Ketamine as a Supplement to Local Anesthesia for Minor Procedures". This trial is a double-blind randomized controlled clinical trial of adults and children (ages 7 to less than 70 years). Patients who present to the ED and who undergo minor bedside procedures that require local anesthesia will be divided into two groups: The first group will be treated with 0.7 mg/...

What is the current status of trial NCT06284473?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 108 participants. The study started on 2022-05-25. Estimated completion is 2028-05-31.

What conditions does trial NCT06284473 study?

This clinical trial studies the following conditions: Abscess, Pain, Procedural, Minor Laceration.

What interventions are being tested in trial NCT06284473?

The interventions under investigation include: Ketamine (DRUG), Saline (OTHER).

Who is sponsoring clinical trial NCT06284473?

This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06284473 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Abscess

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06284473's enrollment target sits among peer trials

108 7th of 13 higher than 7 of 13 other Abscess trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Abscess trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02703207 · 108 participants · NA

    Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD

  • NCT02744677 · 108 participants · NA

    COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

  • NCT02781883 · 108 participants · Phase 2

    Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

  • NCT03848663 · 108 participants · NA

    Visual Remapping to Aid Reading With Field Loss

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06284473, the US trial registry maintained by the National Library of Medicine. NCT06284473 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.